-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I9oDP+Tr543UOgBXE6AbhFtNdyxO1h4WLAnwv1xxU05kxdtznZ1OVR2JDAcEh3qg 3Zx55guCZEqBU8MZvM0GUQ== 0001022079-04-000010.txt : 20040105 0001022079-04-000010.hdr.sgml : 20040105 20040105161938 ACCESSION NUMBER: 0001022079-04-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040101 FILED AS OF DATE: 20040105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZIEGLER JOHN B CENTRAL INDEX KEY: 0001222674 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 04505231 BUSINESS ADDRESS: STREET 1: QUEST DIAGNOSTICS INC STREET 2: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 c0001222674d20040105f4f.xml PRIMARY DOCUMENT X0201 42004-01-0100001022079QUEST DIAGNOSTICS INC DGX0001222674ZIEGLER JOHN BONE MALCOLM AVENUETETERBORONJ076081000Stock Options (Right to buy)73.192004-01-014A04390A2004-01-012014-01-01Common Stock439

439DPursuant to a stockholder agreement between the Issuer and SmithKline Beecham plc (n/k/a GlaxoSmithKline plc), the reporting person has been elected as a director at the designation of GlaxoSmithKline. The reporting person disclaims beneficial ownership of the shares of the Issuer beneficially owned by GlaxoSmithKline. The reporting person is an officer of GlaxoSmithKline.Leo C. Farrenkopf, Jr.2004-01-05 -----END PRIVACY-ENHANCED MESSAGE-----